Continuing Development of Vaccines and Monoclonal Antibodies Against Zika Virus

Overview

Journal NPJ Vaccines

Date 2024 May 24

PMID 38789469

Authors

Sara E Woodson

Kaitlyn M Morabito

Affiliations

Soon will be listed here.

Citing Articles

Congenital Zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface.

Gardinali N, Marchevsky R, Vieira Y, Pelajo-Machado M, Kugelmeier T, Melgaco J Mem Inst Oswaldo Cruz. 2025; 120:e240125.

PMID: 40052994 PMC: 11884655. DOI: 10.1590/0074-02760240125.

Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin.

Hewitt C, Wixon N, Gallegos A, Zhou Y, Huber V, Killian M Vaccines (Basel). 2025; 13(1.

PMID: 39852858 PMC: 11769224. DOI: 10.3390/vaccines13010079.

A Lambda-evo (λ) phage platform for Zika virus E protein display.

Negrete-Mendez H, Valencia-Toxqui G, Martinez-Penafiel E, Medina-Contreras O, Fernandez-Ramirez F, Morales-Rios E Appl Microbiol Biotechnol. 2025; 109(1):8.

PMID: 39820667 PMC: 11739229. DOI: 10.1007/s00253-024-13380-3.

Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques.

Nkolola J, Hope D, Guan R, Colarusso A, Aid M, Weiss D J Virol. 2024; 98(12):e0142924.

PMID: 39545728 PMC: 11650990. DOI: 10.1128/jvi.01429-24.

References

Durham D, Fitzpatrick M, Ndeffo-Mbah M, Parpia A, Michael N, Galvani A . Evaluating Vaccination Strategies for Zika Virus in the Americas. Ann Intern Med. 2018; 168(9):621-630. PMC: 5955609. DOI: 10.7326/M17-0641. View

Connery A, Lamb M, Colbert A, Bauer D, Olson D, Paniagua-Avila A . A prospective cohort study of head circumference and its association with neurodevelopmental outcomes in infants and young children in rural Guatemala. J Dev Orig Health Dis. 2022; 13(6):779-786. DOI: 10.1017/S204017442200023X. View

Essink B, Chu L, Seger W, Barranco E, Le Cam N, Bennett H . The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials. Lancet Infect Dis. 2023; 23(5):621-633. DOI: 10.1016/S1473-3099(22)00764-2. View

Lamb M, Connery A, Colbert A, Bauer D, Olson D, Paniagua-Avila A . Anthropometric proxies for child neurodevelopment in low-resource settings: length- or height-for-age, head circumference or both?. J Dev Orig Health Dis. 2022; 14(1):61-69. PMC: 9845425. DOI: 10.1017/S2040174422000423. View

Woodcock J, LaVange L . Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. N Engl J Med. 2017; 377(1):62-70. DOI: 10.1056/NEJMra1510062. View

Brasil P, Pereira Jr J, Moreira M, Ribeiro Nogueira R, Damasceno L, Wakimoto M . Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med. 2016; 375(24):2321-2334. PMC: 5323261. DOI: 10.1056/NEJMoa1602412. View

Dowd K, Ko S, Morabito K, Yang E, Pelc R, DeMaso C . Rapid development of a DNA vaccine for Zika virus. Science. 2016; 354(6309):237-240. PMC: 5304212. DOI: 10.1126/science.aai9137. View

Han H, Diaz C, Acosta C, Liu M, Borkowski A . Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021; 21(9):1282-1292. DOI: 10.1016/S1473-3099(20)30733-7. View

Branche E, Wang Y, Viramontes K, Valls Cuevas J, Xie J, Ana-Sosa-Batiz F . SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus. Nat Commun. 2022; 13(1):5341. PMC: 9465152. DOI: 10.1038/s41467-022-33041-1. View

10.

Baldwin W, Livengood J, Giebler H, Stovall J, Boroughs K, Sonnberg S . Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice. Sci Rep. 2018; 8(1):16509. PMC: 6220238. DOI: 10.1038/s41598-018-34735-7. View

11.

Raasch L, Yamamoto K, Newman C, Rosinski J, Shepherd P, Razo E . Fetal loss in pregnant rhesus macaques infected with high-dose African-lineage Zika virus. PLoS Negl Trop Dis. 2022; 16(8):e0010623. PMC: 9380952. DOI: 10.1371/journal.pntd.0010623. View

12.

Martinez D, Yount B, Nivarthi U, Munt J, Delacruz M, Whitehead S . Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees. Cell Rep. 2020; 33(1):108226. PMC: 7583086. DOI: 10.1016/j.celrep.2020.108226. View

13.

Louik C, Chambers C, Jacobs D, Rice F, Johnson D, Mitchell A . Influenza vaccine safety in pregnancy: can we identify exposures?. Pharmacoepidemiol Drug Saf. 2012; 22(1):33-9. DOI: 10.1002/pds.3336. View

14.

Vannice K, Giersing B, Kaslow D, Griffiths E, Meyer H, Barrett A . Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency. Vaccine. 2016; 37(50):7443-7450. DOI: 10.1016/j.vaccine.2016.10.034. View

15.

Dudley D, Van Rompay K, Coffey L, Ardeshir A, Keesler R, Bliss-Moreau E . Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates. Nat Med. 2018; 24(8):1104-1107. PMC: 6082723. DOI: 10.1038/s41591-018-0088-5. View

16.

Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney M, Medits I, Sharma A . Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016; 536(7614):48-53. DOI: 10.1038/nature18938. View

17.

Brasil P, Carvalho Sequeira P, dAvila Freitas A, Zogbi H, Amaral Calvet G, de Souza R . Guillain-Barré syndrome associated with Zika virus infection. Lancet. 2016; 387(10026):1482. DOI: 10.1016/S0140-6736(16)30058-7. View

18.

Subramaniam K, Lant S, Goodwin L, Grifoni A, Weiskopf D, Turtle L . Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design. Front Immunol. 2020; 11:517. PMC: 7109261. DOI: 10.3389/fimmu.2020.00517. View

19.

Gilchuk P, Bombardi R, Erasmus J, Tan Q, Nargi R, Soto C . Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics. Nat Biomed Eng. 2020; 4(11):1030-1043. PMC: 7655621. DOI: 10.1038/s41551-020-0594-x. View

20.

Katzelnick L, Zambrana J, Elizondo D, Collado D, Garcia N, Arguello S . Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term. Sci Transl Med. 2021; 13(614):eabg9478. PMC: 8693842. DOI: 10.1126/scitranslmed.abg9478. View